MicroPort Scientific subsidiary Endovastec reports nine-month revenue up 10.26% to RMB 1.12 billionPUBT·Oct 29, 2026 at 01:24 PM008530.00%688016-2.78%
Hong Kong Healthcare Stocks Split: Far Eastern Pharma's FDA Gamble vs. Real Estate QuagmireGlobal Report·Oct 28, 2026 at 10:14 AM01515-2.02%008530.00%
LQIDA's AI Edge Push Drives Hong Kong Small-Cap M&A Surge into Tech, BiotechGlobal Report·Oct 28, 2026 at 09:21 AM01361-0.31%008530.00%
MicroPort Scientific Files List of Board and Committee MembersPUBT·Oct 25, 2026 at 11:55 AM008530.00%
Bailouts vs. Suspensions: Hong Kong's Forgotten Stocks in TurmoilGlobal Report·Oct 21, 2026 at 09:17 AM01364-2.07%00966-1.03%
Weekly Recap | MICROPORT this week, halted with no price changeWeekly Review·Oct 17, 2026 at 06:21 AM008530.00%
A Device Approval, a Frozen Stock: MicroPort NeuroTech's Long HaltGlobal Report·Oct 16, 2026 at 10:47 AM021720.00%008530.00%
Two Value Chains: How Hong Kong's Small Caps Split ApartGlobal Report·Oct 13, 2026 at 10:52 AM00570+0.89%02459-4.39%
Solar Giants Forge Secret Price Pact as Hong Kong Minnows Navigate AI Hype and Governance CrisesGlobal Report·Oct 13, 2026 at 09:24 AM02459-4.39%02605+2.55%
Weekly Recap | MICROPORT this week, halted amid governance disputeWeekly Review·Oct 10, 2026 at 05:50 AM008530.00%
Venus Medtech's state rescue: China's valve makers bet on exportsGlobal Report·Oct 9, 2026 at 10:48 AM02500-3.61%021600.00%
Luxshare's $684M Manufacturing Push Amid MicroPort's Governance QuakeGlobal Report·Oct 6, 2026 at 09:17 AM00290+7.08%008530.00%
Weekly Recap | MICROPORT this week, a quiet, low-volume weekWeekly Review·Oct 3, 2026 at 06:01 AM008530.00%